Skip to main content

Table 1 Demographic and clinical characteristics of the two groups

From: Characteristics of the vaginal microbiome in women with premature ovarian insufficiency

 

POI group (n = 28)a

Control group (n = 12)a

P-value

Age (years)

34.61 ± 4.37

32.5 ± 3.87

0.16

BMI (kg/m2)

21.01 ± 1.19

20.81 ± 1.60

0.66

FSH (mIU/mL)

45.54 ± 30.68

5.41 ± 1.87

< 0.01**

LH (mIU/mL)

16.15 ± 8.35

4.05 ± 1.23

< 0.01**

E2 (pg/L)

32.61 ± 18.86

55.08 ± 9.87

< 0.01**

P (nmol/L)

0.52 ± 0.37

0.35 ± 0.17

0.14

T (nmol/L)

0.44 ± 0.20

0.29 ± 0.12

0.02*

PRL (nmol/L)

14.74 ± 8.51

11.81 ± 4.31

0.27

AMH (ng/mL)

0.54 ± 0.36

4.34 ± 2.15

< 0.01**

FSH/LH (ratio)

2.74 ± 0.71

1.33 ± 0.18

< 0.01**

GLU (nmol/L)

5.18 ± 0.45

4.92 ± 0.28

0.08

  1. POI Premature ovarian insufficiency, BMI Body mass index, FSH Follicle-stimulating hormone, LH Luteinizing hormone, E2 Oestradiol, P Progesterone, T Testosterone, PRL Prolactin, AMH Anti-Müllerian hormone, GLU Glucose
  2. *When P < 0.05, “*” marks the significant
  3. **When P < 0.01, “**” marks significance
  4. aNormally distributed data are expressed as means ± standard deviations
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us